Sino Medical Sciences Technology Inc. (688108.SS)
CNY 10.24
(-0.49%)
CNY 10.24
(-0.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 343.25 Million | 192.85 Million | 194.35 Million | 327.41 Million | 435.91 Million | 380.42 Million |
| Cost of Revenue | 145.63 Million | 71.13 Million | 50.86 Million | 65.81 Million | 74.42 Million | 67.31 Million |
| Gross Profit | 197.62 Million | 121.72 Million | 143.48 Million | 261.6 Million | 361.49 Million | 313.11 Million |
| Operating Expenses | 267.03 Million | 321.73 Million | 299.56 Million | 247.93 Million | 258.57 Million | 210.63 Million |
| Selling, General and Administrative Expenses | 93.99 Million | 83.38 Million | 83.24 Million | 96.18 Million | 125.18 Million | 108.03 Million |
| Research and Development Expenses | 114.09 Million | 152.79 Million | 148.93 Million | 108.73 Million | 89.59 Million | 66.54 Million |
| Other Expenses | -3.41 Million | 85.54 Million | 67.38 Million | 43.01 Million | 43.8 Million | -5.63 Million |
| Cost and Expenses | 412.67 Million | 392.86 Million | 350.42 Million | 313.75 Million | 332.99 Million | 277.94 Million |
| Operating Income | -69.13 Million | -200.01 Million | -156.07 Million | 15.36 Million | 108.58 Million | 108.33 Million |
| Interest Expense | 3.74 Million | 2.54 Million | 2.19 Million | 146.65 Thousand | 162.68 Thousand | 167.45 Thousand |
| Income Tax Expense | -24.45 Million | -48.02 Million | -31.8 Million | 6.34 Million | 17.93 Million | 13.5 Million |
| Earnings before Tax | -69.18 Million | -221.33 Million | -163.1 Million | 28.84 Million | 107.97 Million | 102.69 Million |
| Net Income | -39.63 Million | -173.31 Million | -131.29 Million | 22.49 Million | 90.03 Million | 89.19 Million |
| Earnings Per Share Basic | -0.10 | -0.42 | -0.32 | 0.05 | 0.22 | 0.25 |
| Earnings Per Share Diluted | -0.10 | -0.42 | -0.32 | 0.05 | 0.22 | 0.25 |
| Weighted Average Shares Outstanding | 396.3 Million | 410 Million | 410 Million | 410 Million | 410 Million | 356.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 396.3 Million | 410 Million | 410 Million | 410 Million | 410 Million | 356.76 Million |
| Gross Margin | 0.58 | 0.63 | 0.74 | 0.80 | 0.83 | 0.82 |
| EBIT Margin | 0.01 | -0.72 | -0.45 | 0.16 | 0.30 | 0.33 |
| Profit Margin | -0.12 | -0.90 | -0.68 | 0.07 | 0.21 | 0.23 |
| EBITDA | 3.31 Million | -139.79 Million | -95.49 Million | 50.2 Million | 142.71 Million | 123.2 Million |
| Earnings Before Tax Margin | -0.20 | -1.04 | -0.80 | 0.05 | 0.25 | 0.28 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 104.79 Million | 121.75 Million | 90.4 Million | 98.64 Million | 343.25 Million | 83.33 Million |
| Cost of Revenue | 36.08 Million | 63.39 Million | 41.58 Million | 39.87 Million | 141.02 Million | 32.98 Million |
| Gross Profit | 68.71 Million | 58.36 Million | 48.82 Million | 58.76 Million | 202.23 Million | 50.34 Million |
| Operating Expenses | 75.06 Million | 58.27 Million | 74.97 Million | 111.95 Million | 412.39 Million | 61.08 Million |
| Selling, General and Administrative Expenses | 93.53 Million | 38.07 Million | 35.32 Million | -23.2 Million | - | 69.65 Million |
| Research and Development Expenses | 38.14 Million | 20.61 Million | 36 Million | 33.59 Million | - | 28.08 Million |
| Other Expenses | -56.61 Million | 420.41 Thousand | -3.64 Million | -111.95 Million | -412.39 Million | -31.66 Thousand |
| Cost and Expenses | 111.14 Million | 121.66 Million | 116.56 Million | 111.95 Million | 412.39 Million | 94.07 Million |
| Operating Income | -11.81 Million | 86.09 Thousand | -26.15 Million | -13.31 Million | -69.13 Million | -15.35 Million |
| Interest Expense | 1.38 Million | 1.4 Million | 1.4 Million | 1.18 Million | 3.74 Million | 1.01 Million |
| Income Tax Expense | 3.12 Million | -518.09 Thousand | -4.4 Million | -13.06 Million | -24.45 Million | -2.94 Million |
| Earnings before Tax | -11.98 Million | 3.35 Million | 1.5 Million | -13.15 Million | -69.18 Million | -15.38 Million |
| Net Income | -14.4 Million | 5.16 Million | 2.49 Million | -4.68 Million | -49.31 Million | -12.13 Million |
| Earnings Per Share Basic | -0.03 | 0.01 | 0.01 | -0.01 | - | -0.03 |
| Earnings Per Share Diluted | -0.03 | 0.01 | 0.01 | -0.01 | - | -0.03 |
| Weighted Average Shares Outstanding | 413.45 Million | 413.45 Million | 410 Million | 332.84 Million | 396.3 Million | 410 Million |
| Weighted Average Shares Outstanding (Diluted) | 413.45 Million | 413.45 Million | 410 Million | 332.81 Million | 396.3 Million | 410 Million |
| Gross Margin | 0.66 | 0.48 | 0.54 | 0.60 | 0.59 | 0.60 |
| EBIT Margin | -0.10 | 0.21 | 0.07 | -0.12 | - | -0.14 |
| Profit Margin | -0.14 | 0.04 | 0.03 | -0.05 | -0.14 | -0.15 |
| EBITDA | -10.6 Million | 25.87 Million | 6.48 Million | -11.59 Million | - | -11.63 Million |
| Earnings Before Tax Margin | -0.11 | 0.00 | -0.29 | -0.13 | -0.20 | -0.18 |
688310
RCL
300442
3167
ASG
NOUVEAU